Literature DB >> 12231446

The tau locus is not significantly associated with pathologically confirmed sporadic Parkinson's disease.

Rohan de Silva1, John Hardy, Julia Crook, Naheed Khan, Elizabeth A Graham, Christopher M Morris, Nicholas W Wood, Andrew J Lees.   

Abstract

Mutations of the tau gene in frontotemporal dementia with parkinsonism and genetic association of the tau locus with progressive supranuclear palsy and corticobasal degeneration directly implicate the tau gene in the aetiology of these tauopathies. Three studies have also shown an association of the tau locus with clinically diagnosed Parkinson's disease. Noting the significant incidence of clinical misdiagnosis of Parkinson's disease, we investigated this tau gene association in a series of 157 pathologically confirmed cases of brain stem Lewy body Parkinson's disease by analysing their tau haplotype status. Although H1H1 homozygotes are elevated in the Parkinson's disease cases (63.1%) compared to controls (56.1%) this difference is not significant (P=0.22). These results indicate that any association must either be weak (with an odds ratio of less than 2) or that previous positive associations were due to contamination of clinically diagnosed cases with other diagnostic clinico-pathological entities such as neurofibrillary tangle Parkinson's syndrome.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12231446     DOI: 10.1016/s0304-3940(02)00742-5

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  11 in total

1.  An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology.

Authors:  Christian Wider; Owen A Ross; Kenya Nishioka; Michael G Heckman; Carles Vilariño-Güell; Barbara Jasinska-Myga; Nilufer Erketin-Taner; Rosa Rademakers; Neill R Graff-Radford; Deborah C Mash; Spiridon Papapetropoulos; Ranjan Duara; Hirotake Uchikado; Zbigniew K Wszolek; Matthew J Farrer; Dennis W Dickson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2012-01-30       Impact factor: 10.154

2.  Haplotypes and gene expression implicate the MAPT region for Parkinson disease: the GenePD Study.

Authors:  J E Tobin; J C Latourelle; M F Lew; C Klein; O Suchowersky; H A Shill; L I Golbe; M H Mark; J H Growdon; G F Wooten; B A Racette; J S Perlmutter; R Watts; M Guttman; K B Baker; S Goldwurm; G Pezzoli; C Singer; M H Saint-Hilaire; A E Hendricks; S Williamson; M W Nagle; J B Wilk; T Massood; J M Laramie; A L DeStefano; I Litvan; G Nicholson; A Corbett; S Isaacson; D J Burn; P F Chinnery; P P Pramstaller; S Sherman; J Al-hinti; E Drasby; M Nance; A T Moller; K Ostergaard; R Roxburgh; B Snow; J T Slevin; F Cambi; J F Gusella; R H Myers
Journal:  Neurology       Date:  2008-05-28       Impact factor: 9.910

3.  Association of rs62063857 variant of the saitohin gene with Parkinson's disease.

Authors:  Ezgi Sonmez; Mavi Deniz Ozel; Eylul Ece Islek; Ali Sazci; Halil Atilla Idrisoglu
Journal:  Cell Mol Neurobiol       Date:  2014-08-29       Impact factor: 5.046

4.  Association analysis of MAPT H1 haplotype and subhaplotypes in Parkinson's disease.

Authors:  Cyrus P Zabetian; Carolyn M Hutter; Stewart A Factor; John G Nutt; Donald S Higgins; Alida Griffith; John W Roberts; Berta C Leis; Denise M Kay; Dora Yearout; Jennifer S Montimurro; Karen L Edwards; Ali Samii; Haydeh Payami
Journal:  Ann Neurol       Date:  2007-08       Impact factor: 10.422

5.  Cluster analysis of risk factor genetic polymorphisms in Alzheimer's disease.

Authors:  C N Randall; D Strasburger; J Prozonic; S N Morris; A D Winkie; G R Parker; D Cheng; E M Fennell; I Lanham; N Vakil; J Huang; H Cathcart; R Huang; S E Poduslo
Journal:  Neurochem Res       Date:  2008-02-29       Impact factor: 3.996

6.  Association of the MAPT locus with Parkinson's disease.

Authors:  C Wider; C Vilariño-Güell; B Jasinska-Myga; M G Heckman; A I Soto-Ortolaza; S A Cobb; J O Aasly; J M Gibson; T Lynch; R J Uitti; Z K Wszolek; M J Farrer; O A Ross
Journal:  Eur J Neurol       Date:  2009-11-12       Impact factor: 6.089

7.  Tau acts as an independent genetic risk factor in pathologically proven PD.

Authors:  Gavin Charlesworth; Sonia Gandhi; Jose M Bras; Roger A Barker; David J Burn; Patrick F Chinnery; Stephen M Gentleman; Rita Guerreiro; John Hardy; Janice L Holton; Andrew Lees; Karen Morrison; Una-Marie Sheerin; Nigel Williams; Huw Morris; Tamas Revesz; Nicholas W Wood
Journal:  Neurobiol Aging       Date:  2012-01-04       Impact factor: 4.673

8.  Variation at APOE and STH loci and Alzheimer's disease.

Authors:  Lingjun Zuo; Christopher H van Dyck; Xingguang Luo; Henry R Kranzler; Bao-zhu Yang; Joel Gelernter
Journal:  Behav Brain Funct       Date:  2006-04-07       Impact factor: 3.759

9.  Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.

Authors:  Nikolaos Refenes; Juliane Bolbrinker; Georgios Tagaris; Antonio Orlacchio; Nikolaos Drakoulis; Reinhold Kreutz
Journal:  BMC Neurol       Date:  2009-06-28       Impact factor: 2.474

10.  Tau gene and Parkinson's disease: a case-control study and meta-analysis.

Authors:  D G Healy; P M Abou-Sleiman; A J Lees; J P Casas; N Quinn; K Bhatia; A D Hingorani; N W Wood
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-07       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.